The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of ...

Jazz Pharma has agreed to pay $145 million to settle lawsuits claiming it illegally acted to prevent generic versions of its ...

During a fireside chat at Reuters Pharma Europe 2025, Francesco Di Marco, Global Head of Human Pharma Regions at Boehringer ...

In a fitting embodiment of its own themes, this year, Reuters Pharma Europe 2025 is offering an AI-generated summary of each ...

The US is dangerously close to falling behind China in biotech, and the government should spend a minimum of $15 billion over ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

At the same time that Donald Trump was saying that a "major tariff" on pharmaceuticals is coming to force more manufacturers ...

In this webinar – ‘Enabling Digitally Enhanced Care for Rare Diseases in Europe: Integrating AI and Connected Care ...

AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug ...

The EMA has called a temporary halt to a phase 2 trial of Sarepta's Roche-partnered Duchenne muscular dystrophy (DMD) gene ...

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for ...

UK medtech company Brainomix has been granted FDA approval for a new feature for its artificial intelligence-powered stroke ...